Literature DB >> 1556894

Time-related alteration of endolymph composition in an experimental model of endolymphatic hydrops.

I Sziklai1, E Ferrary, K C Horner, O Sterkers, C Amiel.   

Abstract

The electrochemical changes of the inner ear fluids were studied in the guinea pig during the development of endolymphatic hydrops in an experimental model of Meniere's disease obtained by the blockage of the vestibular aqueduct. The endocochlear potential (first and third turns) was recorded, and the sodium, potassium, and chloride concentrations, and osmolality of the endolymph (first and third turns) and perilymph were determined at different intervals from 2 to 24 weeks after the induction of the hydrops. The development of hydrops was monitored by the compound action potential once a week during the observation period. In normal, nonoperated guinea pigs, longitudinal endolymphatic gradients of endocochlear potential, potassium and chloride concentrations, and osmolality, increasing from the apex to the base of the cochlea, were observed. After 2 weeks of hydrops, no alteration of this pattern was detected. After 6 and 9 weeks of hydrops, a progressive decrease of endocochlear potential, potassium and chloride concentrations, and osmolality was noticed at the first turn (6 and 9 weeks) and then at the third turn (9 weeks) which resulted in the disappearance of longitudinal gradients. At 24 weeks, the endocochlear potential was still diminished by 60%, whereas potassium and chloride concentrations and osmolality increased as compared to 9-week values but remained lower than in controls. The changes in composition of endolymph induced by the development of the hydrops could be related to the progressive alteration of the ionic permeability of the cochlear epithelium, which should be localized at the distended Reissner's membrane.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1556894     DOI: 10.1288/00005537-199204000-00011

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  Large Na(+) influx and high Na(+), K (+)-ATPase activity in mitochondria-rich epithelial cells of the inner ear endolymphatic sac.

Authors:  Takenori Miyashita; Hitoshi Tatsumi; Kimihide Hayakawa; Nozomu Mori; Masahiro Sokabe
Journal:  Pflugers Arch       Date:  2006-12-05       Impact factor: 3.657

2.  Changes in the electrochemical composition of cochlear fluids after intracisternal application of doxorubicin in the rat.

Authors:  I Sziklai; E Ferrary; A Loiseau; O Sterkers; C Amiel
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

Review 3.  Communication pathways to and from the inner ear and their contributions to drug delivery.

Authors:  Alec N Salt; Keiko Hirose
Journal:  Hear Res       Date:  2017-12-19       Impact factor: 3.208

4.  Glucocorticoids stimulate endolymphatic water reabsorption in inner ear through aquaporin 3 regulation.

Authors:  Jérôme Nevoux; Say Viengchareun; Ingrid Lema; Anne-Lise Lecoq; Evelyne Ferrary; Marc Lombès
Journal:  Pflugers Arch       Date:  2014-10-23       Impact factor: 3.657

5.  Early Detection of Endolymphatic Hydrops using the Auditory Nerve Overlapped Waveform (ANOW).

Authors:  C Lee; C V Valenzuela; S S Goodman; D Kallogjeri; C A Buchman; J T Lichtenhan
Journal:  Neuroscience       Date:  2019-12-03       Impact factor: 3.590

6.  Altered calcium homeostasis in the rat cochlear duct and endogenous corticosteroid insufficiency.

Authors:  Y L Ma; K E Rarey; K J Gerhardt; L C Garg; L P Rybak
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

Review 7.  Endolymphatic hydrops: pathophysiology and experimental models.

Authors:  Alec N Salt; Stefan K Plontke
Journal:  Otolaryngol Clin North Am       Date:  2010-10       Impact factor: 3.346

8.  Antidiuretic hormone restores the endolymphatic longitudinal K+ gradient in the Brattleboro rat cochlea.

Authors:  N Julien; A Loiseau; O Sterkers; C Amiel; E Ferrary
Journal:  Pflugers Arch       Date:  1994-03       Impact factor: 3.657

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.